Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Atorvastatin calcium trihydrate
CST Pharma Ltd
C10AA05
Atorvastatin calcium trihydrate
30mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02120000; GTIN: 5055946806372
What is in this leaflet 1. What Atorvastatin is and what it is used for 2. What you need to know before you take Atorvastatin 3. How to take Atorvastatin 4. Possible side effects 5. How to store Atorvastatin 6. Contents of the pack and other information 1. WHAT ATORVASTATIN IS AND WHAT IT IS USED FOR Atorvastatin belongs to a group of medicines known as statins. Statins lower blood cholesterol (and triglycerides). Atorvastatin is advised when a low-fat diet and lifestyle changes have not been adequate to lower blood cholesterol as recommended. If you are at an increased risk of heart disease, Atorvastatin may also be used to reduce such risk even if your blood cholesterol is “normal”. You should maintain a standard cholesterol-lowering diet during treatment. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ATORVASTATIN Do not take Atorvastatin if you • are allergic to atorvastatin or to any similar medicines used to lower blood cholesterol or to any of the other ingredients of this medicine (listed in section 6) • have or have ever had a disease that affects the liver • have had any unexplained abnormal blood tests for liver function • are a woman able to have children and not using reliable contraception • are pregnant or trying to become pregnant • are breast-feeding. Warnings and precautions Talk to your doctor or pharmacist before taking Atorvastatin. The following are reasons why Atorvastatin may not be suitable for you if you have: • had a previous stroke caused by bleeding • kidney problems • an under-active thyroid gland (hypothyroidism) • (or have had) repeated or unexplained muscle aches or pains or a family history of muscle problems. Also tell your doctor or pharmacist if you have a muscle weakness that is constant. Additional tests and medicines may be needed to diagnose and treat this. • had previous muscle problems during treatment with other cholesterol-lowering medicines (i.e. other ‘statin’ or ‘fibrate’ medicines) • had liver disease. also take special care with Atorv read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Atorvastatin 30 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 30 mg of atorvastatin as atorvastatin calcium. Excipient: lactose monohydrate 175 mg/tablet For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. White to almost white, round, slightly convex, film-coated tablets, bevel- edged, tablet diameter 9 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypercholesterolaemia Atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (Corresponding to Types IIa and IIb of the Fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Atorvastatin is also indicated to reduce total-C and LDL-C in adults with homozygous familial hypercholesterolaemia as an adjunct to other lipid-lowering treatments (e.g. LDL apheresis) or if such treatments are unavailable. Prevention of cardiovascular disease Prevention of cardiovascular events in adult patients estimated to have a high risk for a first cardiovascular event (see section 5.1), as an adjunct to correction of other risk factors. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The patient should be placed on a standard cholesterol-lowering diet before receiving Atorvastatin and should continue on this diet during treatment with Atorvastatin. The dose should be individualised according to baseline LDL-C levels, the goal of therapy, and patient response. The usual starting dose is 10 mg once a day. Adjustment of dose should be made at intervals of 4 weeks or more. The maximum dose is 80 mg once a day. _ _ _Primary hypercholesterolaemia and combined (mixed) hyperlipidaemia read_full_document